≡
選單
Goodinfo!
台灣股市資訊網
股票一覽 
 

6535 順藥 / 經營績效(單季)

6535 順藥

日期: 09/23
成交價昨收漲跌價漲跌幅振幅開盤最高最低
82.378+4.3+5.51%6.28%79.182.877.9
成交張數成交金額成交筆數成交均張成交均價PBRPERPEG
3893,137萬730533股/筆80.6611.14N/AN/A
昨日張數昨日金額昨日筆數昨日均張昨日均價昨漲跌價 (幅)
110849.6萬203542張/筆77.22-0.2 (-0.26%)

連續漲跌: 連2跌→漲  ( +4.3元 / +5.51%)

財報評分: 最新45分 / 平均50分

上櫃指數: 413.76 (-1.41 / -0.34%)

新聞及公告

• 晟德轉投資帳列虧損百億元 拖累上半年每股虧11.24元 淨現金流仍達32億元 (Anue鉅亨 08/11 18:35)

• 順藥與安美得生醫股份有限公司簽訂長效止痛針劑東南亞市場授權增補協議 (公告訊息 08/10 18:09)

• 順藥董事會通過解除與巴基斯坦AJM Pharma簽署之「LT1001巴基斯坦專屬授權合約」 (公告訊息 08/10 18:08)

• 順藥董事會通過與烏克蘭Darnytsia藥廠終止LT1001 長效止痛針劑烏克蘭「獨家授權經銷合約」 (公告訊息 08/10 18:08)

• 順藥董事會通過2026年第2季合併財務報告 (公告訊息 08/10 18:07)

• 順藥2026年第二季合併財務報告董事會召開日期 (公告訊息 07/31 15:50)

• 晟德加碼5.5億元投資引正基因 聯手順藥聚焦中樞神經領域 (Anue鉅亨 07/21 19:11)

6535 順藥 單季經營績效

｜
項目： 
輔助：
股本
(億)		財報
評分		季度股價(元)獲利金額(億)獲利率(%)單季
ROE
(%)		年化
ROE
(%)		單季
ROA
(%)		年化
ROA
(%)		EPS(元)BPS
(元)
收盤平均漲跌漲跌
(%)		營業
收入		營業
毛利		營業
利益		業外
損益		稅後
淨利		營業
毛利		營業
利益		業外
損益		稅後
淨利		稅後
EPS		年增
(元)
2026Q3--82.386.3-18.2-18.1----------------
2026Q216.840100.5124-42.5-29.70.050.02-1.21-0.42-1.6231.5-2360-824-3184-12.3-49.3-11.3-45.1-0.97-0.087.39
2026Q116.845143169-51.5-26.50.040.02-0.66-0.54-1.240.6-1483-1210-2693-8.26-33-7.6-30.4-0.72-0.098.33
2025Q416.945194.5219-94-32.60.130.07-0.43-0.14-0.5656.4-333-104-437-3.65-14.6-3.37-13.5-0.33+0.589.01
2025Q316.949288.5192+142+96.90.120.07-0.720.38-0.3363.9-619326-292-2.12-8.47-1.96-7.86-0.2+1.29.45
2025Q216.943146.5159-31.5-17.70.020.02-1.11-0.39-1.4884.6-5100-1780-6880-8.68-34.7-7.88-31.5-0.89-1.39.6
2025Q116.949178230-72-28.80.090.05-1.060.01-1.0458.3-119611.5-1185-5.61-22.5-5.03-20.1-0.63+0.0810.74
2024Q416.947250297-81-24.50.20.09-1.15-0.38-1.4843.1-582-193-775-9.9-39.6-8.75-35-0.91-0.2211.32
2024Q316.545331239+96+40.90.060.03-0.88-1.44-2.2843.3-1379-2253-3632-18-72.1-15.6-62.3-1.4-0.667
2024Q216.572235192+57+320.090.05-0.731.390.6759.1-85916297714.8419.44.2116.80.41+1.338.3
2024Q116.543178139+109.7+1610.040.01-0.81-0.37-1.1630.9-1812-823-2635-8.56-34.2-7.4-29.6-0.71-1.67.84
2023Q416.54568.362.7+5.9+9.50.180.15-1.08-0.12-1.1379.5-583-64.7-647-8.04-32.2-7.05-28.2-0.69-0.938.49
2023Q316.34562.460.5+1.1+1.80.160.14-0.86-0.36-1.286.2-527-224-752-7.62-30.5-6.81-27.2-0.74+0.219.25
2023Q216.34561.351.8+20.15+490.140.11-1.1-0.43-1.5179.8-774-299-1074-8.77-35.1-7.89-31.6-0.92+0.289.97
2023Q116.37241.1541.5+1.75+4.40.080.01-0.732.171.4517.9-910271518058.26337.3929.60.89+2.0310.89
2022Q416.36839.437.1+3.35+9.30.140.1-0.620.920.467-4336412081.837.321.626.490.24+2.439.99
2022Q316.34736.0536.6-0.45-1.20.050.02-0.83-0.71-1.5553.8-1820-1552-3372-9.29-37.1-8.27-33.1-0.95-4.059.74
2022Q216.34336.534.9+1.4+40.050.01-1.01-0.94-1.9529.9-2055-1921-3976-10.6-42.4-9.54-38.1-1.2-0.4610.68
季度股本
(億)		財報
評分		季度股價(元)獲利金額(億)獲利率(%)單季
ROE
(%)		年化
ROE
(%)		單季
ROA
(%)		年化
ROA
(%)		EPS(元)BPS
(元)
收盤平均漲跌漲跌
(%)		營業
收入		營業
毛利		營業
利益		業外
損益		稅後
淨利		營業
毛利		營業
利益		業外
損益		稅後
淨利		稅後
EPS		年增
(元)
2022Q116.34735.137.6-5.15-12.80.030.01-0.6-1.25-1.8536.5-2128-4468-6596-9.1-36.4-8.22-32.9-1.14-1.611.87
2021Q416.34940.2535.3+7+21.10.10.08-1.5-1.78-3.2880.9-1488-1772-3260-15.5-62-14.1-56.3-2.19-1.4912.99
2021Q315.27733.2534.3-4.8-12.60.010-1.035.724.6929.2-1627990237739582599.922.690.23.1+3.513.89
2021Q215.14538.0536.4+2.15+60.040.01-0.93-0.2-1.1222.5-2128-455-2584-6.62-26.5-5.89-23.6-0.74-0.0710.86
2021Q115.17035.934+0.65+1.80.020.01-0.851.520.6825.3-3660657929184.0516.23.614.40.46+1.4111.61
2020Q414.74735.2535.2-2.55-6.70.140.08-0.72-0.13-0.8561.5-534-93-627-7.1-28.4-6.09-24.3-0.7+0.1110.74
2020Q311.85137.841.8-1.35-3.40.010.03-0.880.4-0.47206-62662877-3388-5.68-22.7-4.55-18.2-0.4+0.276.89
2020Q211.84039.1530.8+15.75+67.30.040.01-0.7-0.09-0.7928.6-1578-207-1786-8.8-35.2-6.91-27.7-0.67-0.797.29
2020Q111.85123.430.6-11-320.020.01-1.120-1.1129.9-488120.2-4861-11.2-44.9-8.79-35.2-0.95-0.267.95
2019Q411.84934.432.1+6.05+21.31.61.380.64-1.45-0.9686.340-90.5-59.7-8.76-35-7.36-29.4-0.81-0.928.9
2019Q311.74528.3529.6-2.25-7.40.020.01-0.6-0.19-0.7933.7-2717-848-3565-6.66-26.6-5.97-23.9-0.67-0.539.71
2019Q211.76630.630.2-0.5-1.60.020.01-0.680.810.1433.6-310037226231.124.51.014.030.12+0.4510.38
2019Q111.75131.133.1+0.65+2.10.070.04-0.860.06-0.849.5-118785.6-1102-6.48-25.9-5.85-23.4-0.69-0.5110.26
2018Q411.77230.4531.6-8.55-21.90.190.13-0.570.680.1167.3-30236259.71.154.611.034.140.11+0.6110.93
2018Q39.61513939.7-1.8-4.40.330.26-0.130-0.1380.1-38.5-1.46-39.9-1.93-7.73-1.71-6.86-0.14+0.396.99
2018Q29.584540.841.3-1.4-3.300-0.40.08-0.32-35-278765723-22152-4.57-18.3-4.14-16.6-0.33+0.397.1
2018Q19.545542.235.3+12.7+43.10.090.07-0.290.12-0.1778.4-322134-187-2.41-9.63-2.12-8.49-0.18+0.317.41
2017Q49.545329.530.3-2.3-7.20.030.02-0.470-0.4780.9-154912.9-1536-6.6-26.4-5.7-22.8-0.5+0.187.25
季度股本
(億)		財報
評分		季度股價(元)獲利金額(億)獲利率(%)單季
ROE
(%)		年化
ROE
(%)		單季
ROA
(%)		年化
ROA
(%)		EPS(元)BPS
(元)
收盤平均漲跌漲跌
(%)		營業
收入		營業
毛利		營業
利益		業外
損益		稅後
淨利		營業
毛利		營業
利益		業外
損益		稅後
淨利		稅後
EPS		年增
(元)
2017Q39.544531.835.3-9.2-22.40.020.02-0.49-0.02-0.5181.2-1986-75.7-2062-6.71-26.8-5.95-23.8-0.53+0.347.7
2017Q29.53484142.5-1.8-4.20.050.04-0.56-0.12-0.6987.2-1226-264-1490-8.52-34.1-7.8-31.2-0.72-0.28.19
2017Q19.424842.845.3-1.45-3.30.250.17-0.43-0.04-0.4665.9-170-14.6-184-5.44-21.7-5.11-20.4-0.49+0.148.75
2016Q49.424944.2550.7-21.95-33.200-0.820.23-0.59100-315238963-22560-6.52-26.1-6.24-25-0.68-0.289.26
2016Q39.424866.265.6+12.2+22.600-0.770.03-0.74-----10.7-42.9-10.3-41.4-0.87+0.359.9
2016Q28.4249----0.120.1-0.570.13-0.4480-466109-357-9.2-36.8-8.87-35.5-0.52+0.25.35
2016Q18.4254----00-0.51-0.02-0.53-----10.1-40.5-9.76-39-0.63-0.135.9
2015Q48.4245----0.10.08-0.390.06-0.3380-41161.9-349-5.87-23.5-5.65-22.6-0.4+2.036.51
2015Q38.4248----00-1.10.09-1.01-----16-63.9-15.5-62-1.22-6.95
2015Q28.4254----00-0.60.01-0.6-----8.43-33.7-8.23-32.9-0.72-0.338.05
2015Q18.4248----00-0.450.03-0.42-----5.77-23.1-5.58-22.3-0.5-8.76
2014Q47.8348----00-1.670.09-1.57-----22.3-89.1-21.3-85-2.43-9.03
2014Q27.8348----00-0.250.05-0.2-----2.39-9.56-2.37-9.48-0.39-10.58